Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Open Label Comparative Parallel-group Randomized Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

NCT01804946 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT01804946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01804946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Open Label Comparative Parallel-group Randomized Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2011
Completion date
October 31, 2014
Enrollment
161 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

influenza